바로가기 메뉴
본문내용 바로가기
하단내용 바로가기

논문검색

학회지 > 논문검색
논문 검색
Young Seok Kim, M.D., Bo Rham Jeong, M.D., Jong Won Hong, M.D., Tai Suk Roh, M.D., Dong Kyun Rah, M.D.
Institute for Human Tissue Restoration, Department of Plastic & Reconstructive Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
Temporary Subject
2012 (Feb) 18(01) 1-5
Breast reconstruction, Breast implant, Allograft, Skin substitutes
Ksaps18-2,133-137-01.pdf Ksaps18-2,133-137-01.pdf
Several freeze-dried human acellular dermal matrix have been introduced and they helped to facilitate implant
based breast reconstruction by providing support to the breast lower pole, firm fixation of inframammary
fold, and simple operation procedure. We evaluated clinical outcomes of recently produced human acellular
dermal matrix, CG DermTM, prospectively. CG DermTM was used in six patients and eight breasts for implant
breast reconstruction. Complete blood cell count test, rountine chemisty(including ESR) test, and CRP test
were performed before and after the surgery. Postoperative complication was evaluated including infection,
seroma, implant malpostion, rippling deformity, and capsular contracture. Randomly selected two patients
underwent breast MRI after reconstruction. Finally we examine patients’ satisfaction survey and plastic
surgeons’ evaluation. Satisfactory breast lower pole fullness, symmetric inframammary folds and breast shapes
were achieved in most patients. Overall, patients had sufficient aesthetic satisfaction and surgeon’s evaluation
was also good. There was no major complication except four cases of seroma which healed with conservative
management. Implant breast reconstruction using CG DermTM was safe and obtain good aesthetic results. But
further and larger scale study should be performed to reveal out the relatively high risk of seroma.
(Archives of Aesthetic Plastic Surgery 18: 133, 2012)
김영석, 정보람, 홍종원, 노태석, 나동균
연세대학교 의과대학 강남세브란스병원 성형외과학교실 인체보직복원연구소
보형물을 이용한 유방재건술에서 새롭게 개발된 무세포 동조사체진피(CG Derm) 사용의 유용성에 대한 전향적 연구
2012 (Feb) 18(01) 1-5